Akari Therapeutics Plc Stock Investor Sentiment

AKTX Stock  USD 1.08  0.17  18.68%   
Slightly above 56% of all Akari Therapeutics' investors are looking to take a long position. The analysis of overall sentiment of trading Akari Therapeutics PLC stock suggests that some investors are interested at this time. Akari Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Akari Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Acquisition by Prudo-chlebosz Raymond of 1326258000 shares of Akari Therapeutics at 9.0E-4 subject t...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 1300000 shares by Grissinger Michael of Akari Therapeutics at 0.01 subject to Rule 16...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b...
Macroaxis News
over six months ago at news.google.com         
StockNews.com Begins Coverage on Akari Therapeutics - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Akari Therapeutics that are available to investors today. That information is available publicly through Akari media outlets and privately through word of mouth or via Akari internal channels. However, regardless of the origin, that massive amount of Akari data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Akari Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Akari Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Akari Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Akari Therapeutics alpha.

Akari Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Akari Stock Analysis

When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.